Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

zirconium Zr 89-DFO-starPEG

A radioconjugate containing starPEG, a 4-armed polyethylene glycol (PEG)-based nanodrug carrier moiety, linked, via the chelator desferrioxamine (DFO), to the radioisotope zirconium Zr 89 (Zr89), with potential use as an imaging agent upon positron emission tomography (PET) imaging. Upon administration, starPEG is taken up by tumors due to enhanced permeability and retention (EPR) effect. Upon PET imaging, EPR-mediated tumor uptake and distribution of the nanodrug carrier may be visualized.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	(89Zr)DFO-starPEG 89-Zr-DFO-star polyethylene glycol 89Zr-labeled DFO-starPEG Zr89-DFO-starPEG

zirconium Zr 89-DFO-starPEG

Search NCI's Drug Dictionary